This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Crawford ED et al. (2006) Prostate-specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial. J Urol 175: 1286–1290
Thompson IM et al. (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med 350: 2239–2246
Acknowledgements
The synopsis was written by Tamsin Osborne, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Maroni, P., Crawford, E. Do tumor characteristics and prognostic factors differ between subsequent rounds of PSA screening for prostate cancer?. Nat Rev Urol 4, 252–253 (2007). https://doi.org/10.1038/ncpuro0779
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ncpuro0779